Epidural disposable device market seen reaching $2.79 billion by 2030

The Business Research Company says the epidural anesthesia disposable device market will rise from $1.76 billion in 2025 to $1.93 billion in 2026, then hit $2.79 billion by 2030. Growth is tied to more surgeries, stronger infection-control practices and wider use of single-use anesthesia kits.

Why it matters: - The market is expanding as hospitals and surgical centers lean harder on safer, single-use anesthesia tools. - Rising procedure volumes and infection-prevention demands are pushing demand for disposable epidural devices. - The category matters across both surgical and obstetric care, where epidural anesthesia is widely used for pain management.

What happened: - The Business Research Company published a report on the global epidural anesthesia disposable device market on August 6, 2026. - The report estimates the market will grow from $1.76 billion in 2025 to $1.93 billion in 2026. - The same report projects the market will reach $2.79 billion by 2030. - The forecast implies a 9.7% compound annual growth rate across the period. - North America led the market in 2025.

The details: - Epidural anesthesia disposable devices are sterile, single-use instruments used to deliver epidural anesthesia. - Medical professionals insert the needle into the patient’s back, thread a catheter into the epidural space and deliver anesthesia through the catheter. - The report links historical growth to more surgeries, broader use of epidural anesthesia for pain relief, stronger infection control in hospitals, wider use of regional anesthesia and more skilled anesthesiology professionals. - The report says future growth will also come from more childbirths involving epidural anesthesia, more demand for minimally invasive pain management, expansion of ambulatory surgical centers, healthcare infrastructure development and more emphasis on patient safety and procedural efficiency. - The report highlights growing demand for single-use epidural devices, broader adoption of pre-packaged epidural trays, more frequent use in surgical and obstetric settings, stronger infection-prevention protocols and a shift toward standardized ready-to-use kits. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa, in addition to North America. - The report also includes market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market-hotspot infographics and future trend analysis. - A free sample is available here. - The full report is available here.

Between the lines: - The growth story is less about one new technology and more about routine clinical workflows shifting toward disposable, standardized products. - Infection control and procedural efficiency are doing much of the work here, which fits broader hospital procurement trends. - Rising surgical activity, including liposuction volume cited by the American Society of Plastic Surgeons, helps explain why demand can keep rising across specialties.

What's next: - The market is expected to keep compounding at 9.7% through 2030. - Adoption should continue shifting toward single-use, pre-packaged and ready-to-use epidural products. - Regional opportunities are likely to vary, with North America already leading and other global markets flagged for expansion. - The Business Research Company says its 2026 reports add broader strategic coverage through updated forecasting and market analysis tools.